FDA applicant
Neurometrix, Inc.
FDA records 18 decisions for Neurometrix, Inc. (Waltham, MA) from 1998 to 2022: 17 510(k) clearances and 1 De Novo grant. Most are in product codes JXE (Device, Nerve Conduction Velocity Measurement) and GXY (Electrode, Cutaneous). Its devices cite 34 predicates, 22 of them its own earlier devices. No recall is linked to its devices.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Neurometrix, Inc.’s devices, and how often a recall has named them.
FDA decisions per year
1in 2022
2026 so far, outlined.
Recalls per year
No recall linked to its devices since 2007.
Planning a device like Neurometrix, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) Report